newsfilter
← Latest News
Business Wire·

Natera to Present 35 Studies at ASCO, Extending Clinical Data Leadership in Oncology

Overall program, including 3 oral presentations, delivers unmatched evidence across the MRD landscape Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, today announced a landmark